DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines
2008

DNMT3b Overexpression and Hypermethylation in Breast Cancer

Sample size: 12 publication 10 minutes Evidence: moderate

Author Information

Author(s): Roll J Devon, Rivenbark Ashley G, Jones Wendell D, Coleman William B

Primary Institution: University of North Carolina, Chapel Hill, NC, USA

Hypothesis

Does DNMT3b overexpression contribute to a hypermethylator phenotype in breast cancer cell lines?

Conclusion

The study suggests that a subset of breast cancer cell lines exhibits a hypermethylator phenotype linked to DNMT3b overexpression.

Supporting Evidence

  • A subset of breast cancer cell lines express a hypermethylator phenotype.
  • Hypermethylator cell lines show high rates of concurrent methylation of six genes.
  • Overexpression of DNMT3b protein significantly contributes to elevated DNMT activity.
  • 100% of tumors expressing the hypermethylator signature were classified as basal-like.

Takeaway

Some breast cancer cells have a problem where certain genes are turned off because of too much DNA 'glue' called methylation, and this is linked to a protein called DNMT3b being too active.

Methodology

The study analyzed gene expression and promoter methylation in 12 breast cancer cell lines using RT-PCR, quantitative real-time PCR, and methylation-specific PCR.

Limitations

The study primarily focuses on cell lines, which may not fully represent primary breast tumors.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1186/1476-4598-7-15

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication